These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 61952)

  • 41. [Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
    Germain L; Frexinos J; Louis A; Ribet A
    Arch Fr Mal App Dig; 1973 Jun; 62(4):293-302. PubMed ID: 4594755
    [No Abstract]   [Full Text] [Related]  

  • 42. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial.
    Lee EY; Lee EB; Park BJ; Lee CK; Yoo B; Lim MK; Shim SC; Sheen DH; Seo YI; Kim HA; Baek HJ; Song YW
    Clin Ther; 2006 Dec; 28(12):2052-60. PubMed ID: 17296461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the bronchodilatory action and side-effects of ipratropium bromide and thiazinamium methyl sulphate: a long-term, double-blind, crossover trial in patients with chronic bronchitis.
    Verheijen-Breemhaar L; Bogaard JM; Hilvering C
    Pharmatherapeutica; 1982; 3(3):180-7. PubMed ID: 6127719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Practical experiences in the treatment of gallbladder diseases].
    Panijel M
    Med Welt; 1982 Jul; 33(27):999-1000. PubMed ID: 6924036
    [No Abstract]   [Full Text] [Related]  

  • 45. [Results of a combined therapy of complex digestive disorders using pancreatin and dimethylpolysiloxane (preparation Pankrecura)].
    Schnelle K
    ZFA (Stuttgart); 1977 Jun; 53(16):962-4. PubMed ID: 331714
    [No Abstract]   [Full Text] [Related]  

  • 46. Lactulose syrup assessed in a double-blind study of elderly constipated patients.
    Sanders JF
    J Am Geriatr Soc; 1978 May; 26(5):236-9. PubMed ID: 346631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of four days of preoperative lactulose on posthaemorrhoidectomy pain: results of placebo controlled trial.
    London NJ; Bramley PD; Windle R
    Br Med J (Clin Res Ed); 1987 Aug; 295(6594):363-4. PubMed ID: 3115449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Lactulose therapy for chronic renal failure].
    Miyazaki M; Aoyagi K; Tojo S
    Nihon Jinzo Gakkai Shi; 1984 Aug; 26(8):1091-8. PubMed ID: 6513180
    [No Abstract]   [Full Text] [Related]  

  • 49. [The syndrome of upper abdomen. Organ findings as sequelae of functional disorders].
    Dorn M
    ZFA (Stuttgart); 1977 Sep; 53(27):1638-47. PubMed ID: 303843
    [No Abstract]   [Full Text] [Related]  

  • 50. Tolerability of fentonium bromide in Indonesian volunteers.
    Wilmana PF; Istiantoro J; Sinto A; Darmansjah I
    Curr Med Res Opin; 1977; 5(3):284-8. PubMed ID: 162668
    [No Abstract]   [Full Text] [Related]  

  • 51. [Panpur. Contribution to ambulatory treatment of digestive insufficiency].
    Allwein O; Luther P; Krohn E
    ZFA (Stuttgart); 1977 Nov; 53(31):1977-9. PubMed ID: 595808
    [No Abstract]   [Full Text] [Related]  

  • 52. Pankreoflat in benign diseases of the oesophagus: a blind therapeutic trial.
    Silber W
    S Afr Med J; 1973 Jul; 47(26):1137-8. PubMed ID: 4577798
    [No Abstract]   [Full Text] [Related]  

  • 53. Letter: Spasmocanulase in functional bowel disorder, and the importance of pretrial assessment in evaluation of side-effects.
    Barbezat GO; Bank S
    S Afr Med J; 1974 Nov; 48(53):2205. PubMed ID: 4610813
    [No Abstract]   [Full Text] [Related]  

  • 54. [Therapeutic evaluation of 4-methylumbelliferone in biliary diseases by a double blind method].
    Hirayama C; Okumura M; Nakane M; Baba K; Furukawa K
    Nihon Shokakibyo Gakkai Zasshi; 1972 Jan; 69(1):104-13. PubMed ID: 4573687
    [No Abstract]   [Full Text] [Related]  

  • 55. Double-blind controlled trial of the new preparation FZ. 560 in the symptomatic treatment of digestive disorders.
    Porsio A; Borgia M
    Int J Clin Pharmacol Biopharm; 1976 Jul; 14(1):40-3. PubMed ID: 61952
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Controlled clinical study of a new preparation for the treatment of digestive disorders].
    Mereto GC
    Minerva Gastroenterol; 1975; 21(1):31-4. PubMed ID: 1207938
    [No Abstract]   [Full Text] [Related]  

  • 57. Controlled double-blind trial on the clinical effects of the chenodeoxycholic acid-fentonium bromide combination in the symptomatic treatment of biliary spastic-dyskinetic conditions.
    Ricciardi S; Cerqua R
    Arzneimittelforschung; 1977; 27(6):1226-30. PubMed ID: 332188
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical evaluation of a new preparation with digestive-antispastic activity].
    De Benedictis N; Ferro GF
    Minerva Gastroenterol; 1972; 18(1):35-44. PubMed ID: 4614109
    [No Abstract]   [Full Text] [Related]  

  • 59. [The effect and tolerance of a gall-enzyme preparation].
    Gross W; Kaiser HJ
    Med Welt; 1978 Jan; 29(4):144-9. PubMed ID: 345040
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical research on a new preparation with digestive-antispastic activity].
    Delpiano G; Babbini M
    Minerva Gastroenterol; 1972; 18(1):18-26. PubMed ID: 4614107
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.